Western Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.42M | Buy |
37,440
+625
| +2% | +$134K | 0.31% | 59 |
|
|
2026
Q1 | $8.01M | Buy |
36,815
+13,001
| +55% | +$2.88M | 0.3% | 59 |
|
|
2025
Q4 | $5.44M | Buy |
23,814
+1,985
| +9% | +$452K | 0.25% | 73 |
|
|
2025
Q3 | $5.05M | Buy |
21,829
+85
| +0.4% | +$17.3K | 0.27% | 74 |
|
|
2025
Q2 | $4.04M | Buy |
21,744
+252
| +1% | +$46.8K | 0.24% | 88 |
|
|
2025
Q1 | $4.5M | Sell |
21,492
-13,797
| -39% | -$2.68M | 0.3% | 73 |
|
|
2024
Q4 | $6.27M | Sell |
35,289
-807
| -2% | -$148K | 0.34% | 57 |
|
|
2024
Q3 | $7.13M | Buy |
36,096
+15,299
| +74% | +$2.86M | 0.41% | 47 |
|
|
2024
Q2 | $3.57M | Buy |
20,797
+539
| +3% | +$89.3K | 0.26% | 76 |
|
|
2024
Q1 | $3.69M | Sell |
20,258
-15,061
| -43% | -$2.6M | 0.29% | 74 |
|
|
2023
Q4 | $5.47M | Sell |
35,319
-2,002
| -5% | -$292K | 0.39% | 50 |
|
|
2023
Q3 | $5.56M | Buy |
37,321
+1,075
| +3% | +$158K | 0.47% | 41 |
|
|
2023
Q2 | $4.88M | Sell |
36,246
-1,706
| -4% | -$250K | 0.42% | 43 |
|
|
2023
Q1 | $6.05M | Buy |
37,952
+4,509
| +13% | +$689K | 0.56% | 33 |
|
|
2022
Q4 | $5.4M | Sell |
33,443
-21,821
| -39% | -$3.35M | 0.55% | 36 |
|
|
2022
Q3 | $7.6M | Sell |
55,264
-246
| -0.4% | -$35.3K | 0.44% | 42 |
|
|
2022
Q2 | $8.5M | Sell |
55,510
-1,124
| -2% | -$172K | 0.49% | 40 |
|
|
2022
Q1 | $9.18M | Buy |
56,634
+33,597
| +146% | +$4.88M | 0.45% | 41 |
|
|
2021
Q4 | $3.12M | Buy |
+23,037
| New | +$2.72M | 0.31% | 67 |
|
|
2021
Q2 | $3.29M | Buy |
29,172
+11,255
| +63% | +$1.27M | 0.34% | 64 |
|
|
2021
Q1 | $1.94M | Buy |
17,917
+672
| +4% | +$71.9K | 0.26% | 86 |
|
|
2020
Q4 | $1.85M | Sell |
17,245
-359
| -2% | -$34.5K | 0.27% | 89 |
|
|
2020
Q3 | $1.54M | Buy |
17,604
+1,285
| +8% | +$121K | 0.25% | 100 |
|
|
2020
Q2 | $1.6M | Buy |
16,319
+4,529
| +38% | +$399K | 0.29% | 82 |
|
|
2020
Q1 | $901K | Buy |
11,790
+3,416
| +41% | +$291K | 0.21% | 115 |
|
|
2019
Q4 | $741K | Buy |
8,374
+448
| +6% | +$37.2K | 0.11% | 173 |
|
|
2019
Q3 | $605K | Sell |
7,926
-1,931
| -20% | -$132K | 0.13% | 185 |
|
|
2019
Q2 | $715K | Sell |
9,857
-1,295
| -12% | -$102K | 0.09% | 171 |
|
|
2019
Q1 | $900K | Buy |
11,152
+217
| +2% | +$17.8K | 0.2% | 126 |
|
|
2018
Q4 | $1.01M | Buy |
+10,935
| New | +$962K | 0.27% | 87 |
|
Other funds holding ABBV
Western Wealth Management's ABBV Position: Q2 2026 in Review
Western Wealth Management increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $134K and bringing the position to 37,440 shares worth $9.42M. The position accounts for 0.31% of the portfolio, ranked #59.
Western Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Western Wealth Management held 37,440 shares of AbbVie worth $9.42M as of Q2 2026.
- Western Wealth Management bought 625 AbbVie shares in Q2 2026, an estimated $134K.
- AbbVie made up 0.31% of Western Wealth Management's portfolio in Q2 2026, its #59 holding.
- Western Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.